chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Pain, Pyrexia, Swelling face, Urticaria
Clinical narrative: Fever; achy; Allergic reaction; face swelling; Hives; This is a spontaneous report from a contactable consumer (patient).  A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient medical history included UTI from an unknown date. Concomitant medications were not reported. The patient previously received Cipro for UTI and she never had a problem with Cipro previously. The patient experienced fever, achy, allergic reaction, face swelling, hives on an unspecified date. The caller had the first Pfizer Covid-19 vaccine. She had the Pfizer covid shot and had been normal. She felt a little fever and was achy, but nothing major. About a week out, all of a sudden she got an allergic reaction. They weren't sure, but she had taken Cipro for a UTI. She never had a problem with Cipro previously. However, she had face swelling and hives. She had to stop taking the Cipro. She received a shot of steroids because the Benadryl was not working. The Benadryl was not working for an allergic reaction that occurred. The outcome of the events was unknown.  No follow-up attempts are Possible; information about lot/batch number cannot be obtained.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Ear discomfort, Ear pain, Goitre, Thyroid mass, Ultrasound thyroid
Clinical narrative: They found a nodules 4 mm on right side and a 2 mm and a 3 mm on the left side; Getting ear pressure in right ear; Ear ache on right side of my ear and kind of went down to my throat when you get hoarse, when you get sore throat, trouble right side of my neck around thyroid area; swollen; Ear ache on right side of my ear and kind of went down to my throat when you get hoarse, when you get sore throat, trouble right side of my neck around thyroid area; swollen; This is a spontaneous report from a contactable consumer. This 59-year-old female patient reported for herself. A 59-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: EP7534), dose 1 via an unspecified route of administration, administered in Arm Right on an unspecified date as a single dose for covid-19 immunization. Medical history included blood glucose- an elevated A1C last year, cardiac disorder -Husband has heart issues. Concomitant medication(s) included telmisartan; glipizide ER; empagliflozin (JARDIANCE); rabeprazole; estradiol; mirabegron (MYRBETRIQ). On 24Mar2021, about 3, 4 days later she noticed that getting like an ear pressure, ear ache on the right side of her ear and kind of went down to throat like a when you a get hoarse, when you get a sore throat and had trouble in neck around the thyroid area on the right side of the neck was swollen and lasted for about 3 days. She went to ENT yesterday, by Tuesday it had already gone down but she went yesterday, Wednesday to my ENT to be on the safe side, have it checked out to make sure it was nothing serious. She guess it went down, the swelling and haven't done a blood work yet. On 07Apr2021, they found a nodules 4 mm on right side and a 2 mm and a 3 mm on the left side and they will doing biopsy on the right side. On the neck it just feels very slight. It's kind of very hard to tell if it went completely down or it just the thyroid. She was not sure. There was no soreness to it like it was before. She will be taking the 2nd dose on the April 11th. The patient did not receive any treatment. Outcome of the event thyroid mass was recovering and rest all events was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Lymphadenopathy, Pain, Pain in extremity
Clinical narrative: sore/achy; she had fever of 101; Body chills; lymph node reaction everywhere; sore arm; burning immediately at site; This is a spontaneous report from a contactable consumer (patient). A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0150) via an unspecified route of administration in the left arm on 07Apr2021 at 17:15 (at the age of 49-years-old) as dose 2, single for COVID-19 immunisation. Medical history included paroxysmal atrial fibrillation (reported as Paroxmal afib), supraventricular tachycardia (SVT), graves' disease and hashimoto's disease. Concomitant medications taken within two weeks prior to vaccination included levothyroxine sodium (TIROSINT), via unspecified route of administration from unknown date to unknown date at unknown dose and frequency for an unspecified indication; hydrochlorothiazide (HCTZ) (reported as hgtz), via unspecified route of administration from unknown date to unknown date at unknown dose and frequency for an unspecified indication; atenolol (ATENOL), via unspecified route of administration from unknown date to unknown date at unknown dose and frequency for an unspecified indication; vitamin d nos (VITAMIN D), via unspecified route of administration from unknown date to unknown date at unknown dose and frequency for an unspecified indication and potassium (MANUFACTURER UNKNOWN), via unspecified route of administration from unknown date to unknown date at unknown dose and frequency for an unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6199) via an unspecified route of administration in the left arm on 17Mar2021 at 17:15 (at the age of 48-years-old) as a dose 1, single for COVID-19 immunisation and had got a raised red bump for a day. The patient was not a pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 17:15, when given the second shot of injection the patient had a burning immediately at site. On 08Apr2021 (next day), the patient woke up sore arm and but sore by 15:30 she had fever of 101, Body chills, achy and lymph node reaction everywhere. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The patient underwent lab tests which included body temperature with 101 (units unspecified) on 08Apr2021 fever of 101. The clinical outcome of the events were recovering.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: sore/achy; she had fever of 101; Body chills; lymph node reaction everywhere; sore arm; burning immediately at site; This is a spontaneous report from a contactable consumer (patient). A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0150) via an unspecified route of administration in the left arm on 07Apr2021 at 17:15 (at the age of 49-years-old) as dose 2, single for COVID-19 immunisation. Medical history included paroxysmal atrial fibrillation (reported as Paroxmal afib), supraventricular tachycardia (SVT), graves' disease and hashimoto's disease. Concomitant medications taken within two weeks prior to vaccination included levothyroxine sodium (TIROSINT), via unspecified route of administration from unknown date to unknown date at unknown dose and frequency for an unspecified indication; hydrochlorothiazide (HCTZ) (reported as hgtz), via unspecified route of administration from unknown date to unknown date at unknown dose and frequency for an unspecified indication; atenolol (ATENOL), via unspecified route of administration from unknown date to unknown date at unknown dose and frequency for an unspecified indication; vitamin d nos (VITAMIN D), via unspecified route of administration from unknown date to unknown date at unknown dose and frequency for an unspecified indication and potassium (MANUFACTURER UNKNOWN), via unspecified route of administration from unknown date to unknown date at unknown dose and frequency for an unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6199) via an unspecified route of administration in the left arm on 17Mar2021 at 17:15 (at the age of 48-years-old) as a dose 1, single for COVID-19 immunisation and had got a raised red bump for a day. The patient was not a pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 17:15, when given the second shot of injection the patient had a burning immediately at site. On 08Apr2021 (next day), the patient woke up sore arm and but sore by 15:30 she had fever of 101, Body chills, achy and lymph node reaction everywhere. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The patient underwent lab tests which included body temperature with 101 (units unspecified) on 08Apr2021 fever of 101. The clinical outcome of the events were recovering.  No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pruritus, Skin warm, Swelling
Clinical narrative: Entire shoulder swollen; Underarm glands swollen all the way down to breast area, collarbone gland swelling; All areas affected are hot; All areas affected are itchy. All on left arm. Still swollen after 48 hrs; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: ER8737) via an unspecified route of administration in the left arm on 06Apr2021 at 13:00 (at the age of 44-year-old) as a single dose for COVID-19 immunization. Medical history included hypertension and allergies to food. Concomitant medications included losartan and zolpidem. The patient previously took sulfa and experienced sulfonamide allergy and Keflex and experienced drug allergy to Keflex. Historical vaccine included first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: EN6208) via an unspecified route of administration in the left arm on 16Mar2021 at 13:00 (at the age of 44-year-old) as a single dose for COVID-19 immunisation and experienced large hive/welt the size of a fist over the vaccine site in her left arm for two plus weeks. It was hot and itchy. She had large lump underneath. It left a mark which may be permanent. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021 after the second vaccine, the patient experienced entire shoulder swollen, underarm glands swollen all the way down to breast area and collarbone gland swelling. All areas affected were hot and itchy. All on left arm. It was still swollen after 48 hours. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. The clinical outcome of the events after the second vaccine, entire shoulder was swollen, underarm glands swollen all the way down to breast area, collarbone gland swelling, all areas affected were hot and itchy, all on left arm and it was still swollen after 48 hours was not resolved at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Abnormal dreams, Aphonia, Arthralgia, Asthenia, Back pain
Clinical narrative: back pain; Losing voice; pain in check bones; neck swollen; Rainy day blues; Tiredness; Muscle pain; extreme pain in bones; Chill; Hot; Cold; joint pain; fever; runny nose; nausea; throwing up; lack of appetite; weird dreams; sleep for short times; glands swollen in neck; sore throat; sore mouth; earache; vision poor; extremely rough 15 to 20 on pain scale/ every part of her body hurt; lost 7 and 1/2 pounds; feeling sick; weak; rash/ rash under chin, on arm; tender to the touch; Injection site pain; Injection site redness; Injection site hot to the touch; This is a spontaneous report from a contactable consumer. A 87-year-old non-pregnant female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: ER2613), dose 2 via an un-specified route of administration, administered in Arm Left on 18Mar2021 11:15 as dose 2, single for covid-19 immunisation (at the age of 87-year-old). The patient medical history was not reported. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not received any other medications within 2 weeks of vaccination. The patient previously received first dose of bnt162b2 on an unspecified date for covid-19 immunisation. On 18Mar2021 patient experienced Injection site pain, Injection site redness, Injection site hot to the touch, Thursday 11:15 am shot felt ok through dinner and supper by 8pm feeling sick till Saturday 20Mar then just week , rash and tender to the touch. Friday was extremely rough 15 to 20 on pain scale lost 7 and1/2 pounds. On 20Mar2021 Saturday patient experienced tiredness, Muscle pain, extreme pain in bones every part of her body hurt. Chill, Hot, Cold, joint pain, fever, runny nose, nausea, throwing up, lack of appetite, rash under chin, on arm, weak, weird dreams, when she did sleep and only sleep for short times, glands swollen in neck, sore throat sore mouth, earache, vision poor. Sunday finally ok. Monday (23Mar2021) still week and tired. Tuesday (24Mar2021) Slept late, rashes gone, neck swollen, Rainy day blues. Wednesday (25Mar2021) much back pain during the night took a pain pill (Naproxen) Unger Menthol ointment. Losing voice, feeing weak, need asthma inhaler, pain in check bones, Still feeling weak on the 09Apr2021. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The treatment was not received for adverse event. The patient underwent lab tests and procedures which included pain assessment: 15 to 20 on 19Mar2021, weight decreased: 7 and 1/2 lbs on 19Mar2021. The outcome of the event rash/ rash under chin, on arm was recovered on 24Mar2021. The outcome for other events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Chills, Decreased appetite, Ear pain, Facial pain
Clinical narrative: back pain; Losing voice; pain in check bones; neck swollen; Rainy day blues; Tiredness; Muscle pain; extreme pain in bones; Chill; Hot; Cold; joint pain; fever; runny nose; nausea; throwing up; lack of appetite; weird dreams; sleep for short times; glands swollen in neck; sore throat; sore mouth; earache; vision poor; extremely rough 15 to 20 on pain scale/ every part of her body hurt; lost 7 and 1/2 pounds; feeling sick; weak; rash/ rash under chin, on arm; tender to the touch; Injection site pain; Injection site redness; Injection site hot to the touch; This is a spontaneous report from a contactable consumer. A 87-year-old non-pregnant female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: ER2613), dose 2 via an un-specified route of administration, administered in Arm Left on 18Mar2021 11:15 as dose 2, single for covid-19 immunisation (at the age of 87-year-old). The patient medical history was not reported. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not received any other medications within 2 weeks of vaccination. The patient previously received first dose of bnt162b2 on an unspecified date for covid-19 immunisation. On 18Mar2021 patient experienced Injection site pain, Injection site redness, Injection site hot to the touch, Thursday 11:15 am shot felt ok through dinner and supper by 8pm feeling sick till Saturday 20Mar then just week , rash and tender to the touch. Friday was extremely rough 15 to 20 on pain scale lost 7 and1/2 pounds. On 20Mar2021 Saturday patient experienced tiredness, Muscle pain, extreme pain in bones every part of her body hurt. Chill, Hot, Cold, joint pain, fever, runny nose, nausea, throwing up, lack of appetite, rash under chin, on arm, weak, weird dreams, when she did sleep and only sleep for short times, glands swollen in neck, sore throat sore mouth, earache, vision poor. Sunday finally ok. Monday (23Mar2021) still week and tired. Tuesday (24Mar2021) Slept late, rashes gone, neck swollen, Rainy day blues. Wednesday (25Mar2021) much back pain during the night took a pain pill (Naproxen) Unger Menthol ointment. Losing voice, feeing weak, need asthma inhaler, pain in check bones, Still feeling weak on the 09Apr2021. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The treatment was not received for adverse event. The patient underwent lab tests and procedures which included pain assessment: 15 to 20 on 19Mar2021, weight decreased: 7 and 1/2 lbs on 19Mar2021. The outcome of the event rash/ rash under chin, on arm was recovered on 24Mar2021. The outcome for other events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Feeling cold, Feeling hot, Lymphadenopathy
Clinical narrative: back pain; Losing voice; pain in check bones; neck swollen; Rainy day blues; Tiredness; Muscle pain; extreme pain in bones; Chill; Hot; Cold; joint pain; fever; runny nose; nausea; throwing up; lack of appetite; weird dreams; sleep for short times; glands swollen in neck; sore throat; sore mouth; earache; vision poor; extremely rough 15 to 20 on pain scale/ every part of her body hurt; lost 7 and 1/2 pounds; feeling sick; weak; rash/ rash under chin, on arm; tender to the touch; Injection site pain; Injection site redness; Injection site hot to the touch; This is a spontaneous report from a contactable consumer. A 87-year-old non-pregnant female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: ER2613), dose 2 via an un-specified route of administration, administered in Arm Left on 18Mar2021 11:15 as dose 2, single for covid-19 immunisation (at the age of 87-year-old). The patient medical history was not reported. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not received any other medications within 2 weeks of vaccination. The patient previously received first dose of bnt162b2 on an unspecified date for covid-19 immunisation. On 18Mar2021 patient experienced Injection site pain, Injection site redness, Injection site hot to the touch, Thursday 11:15 am shot felt ok through dinner and supper by 8pm feeling sick till Saturday 20Mar then just week , rash and tender to the touch. Friday was extremely rough 15 to 20 on pain scale lost 7 and1/2 pounds. On 20Mar2021 Saturday patient experienced tiredness, Muscle pain, extreme pain in bones every part of her body hurt. Chill, Hot, Cold, joint pain, fever, runny nose, nausea, throwing up, lack of appetite, rash under chin, on arm, weak, weird dreams, when she did sleep and only sleep for short times, glands swollen in neck, sore throat sore mouth, earache, vision poor. Sunday finally ok. Monday (23Mar2021) still week and tired. Tuesday (24Mar2021) Slept late, rashes gone, neck swollen, Rainy day blues. Wednesday (25Mar2021) much back pain during the night took a pain pill (Naproxen) Unger Menthol ointment. Losing voice, feeing weak, need asthma inhaler, pain in check bones, Still feeling weak on the 09Apr2021. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The treatment was not received for adverse event. The patient underwent lab tests and procedures which included pain assessment: 15 to 20 on 19Mar2021, weight decreased: 7 and 1/2 lbs on 19Mar2021. The outcome of the event rash/ rash under chin, on arm was recovered on 24Mar2021. The outcome for other events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Nausea, Oral pain, Oropharyngeal pain
Clinical narrative: back pain; Losing voice; pain in check bones; neck swollen; Rainy day blues; Tiredness; Muscle pain; extreme pain in bones; Chill; Hot; Cold; joint pain; fever; runny nose; nausea; throwing up; lack of appetite; weird dreams; sleep for short times; glands swollen in neck; sore throat; sore mouth; earache; vision poor; extremely rough 15 to 20 on pain scale/ every part of her body hurt; lost 7 and 1/2 pounds; feeling sick; weak; rash/ rash under chin, on arm; tender to the touch; Injection site pain; Injection site redness; Injection site hot to the touch; This is a spontaneous report from a contactable consumer. A 87-year-old non-pregnant female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: ER2613), dose 2 via an un-specified route of administration, administered in Arm Left on 18Mar2021 11:15 as dose 2, single for covid-19 immunisation (at the age of 87-year-old). The patient medical history was not reported. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not received any other medications within 2 weeks of vaccination. The patient previously received first dose of bnt162b2 on an unspecified date for covid-19 immunisation. On 18Mar2021 patient experienced Injection site pain, Injection site redness, Injection site hot to the touch, Thursday 11:15 am shot felt ok through dinner and supper by 8pm feeling sick till Saturday 20Mar then just week , rash and tender to the touch. Friday was extremely rough 15 to 20 on pain scale lost 7 and1/2 pounds. On 20Mar2021 Saturday patient experienced tiredness, Muscle pain, extreme pain in bones every part of her body hurt. Chill, Hot, Cold, joint pain, fever, runny nose, nausea, throwing up, lack of appetite, rash under chin, on arm, weak, weird dreams, when she did sleep and only sleep for short times, glands swollen in neck, sore throat sore mouth, earache, vision poor. Sunday finally ok. Monday (23Mar2021) still week and tired. Tuesday (24Mar2021) Slept late, rashes gone, neck swollen, Rainy day blues. Wednesday (25Mar2021) much back pain during the night took a pain pill (Naproxen) Unger Menthol ointment. Losing voice, feeing weak, need asthma inhaler, pain in check bones, Still feeling weak on the 09Apr2021. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The treatment was not received for adverse event. The patient underwent lab tests and procedures which included pain assessment: 15 to 20 on 19Mar2021, weight decreased: 7 and 1/2 lbs on 19Mar2021. The outcome of the event rash/ rash under chin, on arm was recovered on 24Mar2021. The outcome for other events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain assessment, Pyrexia, Rash, Rhinorrhoea
Clinical narrative: back pain; Losing voice; pain in check bones; neck swollen; Rainy day blues; Tiredness; Muscle pain; extreme pain in bones; Chill; Hot; Cold; joint pain; fever; runny nose; nausea; throwing up; lack of appetite; weird dreams; sleep for short times; glands swollen in neck; sore throat; sore mouth; earache; vision poor; extremely rough 15 to 20 on pain scale/ every part of her body hurt; lost 7 and 1/2 pounds; feeling sick; weak; rash/ rash under chin, on arm; tender to the touch; Injection site pain; Injection site redness; Injection site hot to the touch; This is a spontaneous report from a contactable consumer. A 87-year-old non-pregnant female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: ER2613), dose 2 via an un-specified route of administration, administered in Arm Left on 18Mar2021 11:15 as dose 2, single for covid-19 immunisation (at the age of 87-year-old). The patient medical history was not reported. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not received any other medications within 2 weeks of vaccination. The patient previously received first dose of bnt162b2 on an unspecified date for covid-19 immunisation. On 18Mar2021 patient experienced Injection site pain, Injection site redness, Injection site hot to the touch, Thursday 11:15 am shot felt ok through dinner and supper by 8pm feeling sick till Saturday 20Mar then just week , rash and tender to the touch. Friday was extremely rough 15 to 20 on pain scale lost 7 and1/2 pounds. On 20Mar2021 Saturday patient experienced tiredness, Muscle pain, extreme pain in bones every part of her body hurt. Chill, Hot, Cold, joint pain, fever, runny nose, nausea, throwing up, lack of appetite, rash under chin, on arm, weak, weird dreams, when she did sleep and only sleep for short times, glands swollen in neck, sore throat sore mouth, earache, vision poor. Sunday finally ok. Monday (23Mar2021) still week and tired. Tuesday (24Mar2021) Slept late, rashes gone, neck swollen, Rainy day blues. Wednesday (25Mar2021) much back pain during the night took a pain pill (Naproxen) Unger Menthol ointment. Losing voice, feeing weak, need asthma inhaler, pain in check bones, Still feeling weak on the 09Apr2021. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The treatment was not received for adverse event. The patient underwent lab tests and procedures which included pain assessment: 15 to 20 on 19Mar2021, weight decreased: 7 and 1/2 lbs on 19Mar2021. The outcome of the event rash/ rash under chin, on arm was recovered on 24Mar2021. The outcome for other events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep disorder, Swelling, Tenderness, Vaccination site erythema, Vaccination site pain
Clinical narrative: back pain; Losing voice; pain in check bones; neck swollen; Rainy day blues; Tiredness; Muscle pain; extreme pain in bones; Chill; Hot; Cold; joint pain; fever; runny nose; nausea; throwing up; lack of appetite; weird dreams; sleep for short times; glands swollen in neck; sore throat; sore mouth; earache; vision poor; extremely rough 15 to 20 on pain scale/ every part of her body hurt; lost 7 and 1/2 pounds; feeling sick; weak; rash/ rash under chin, on arm; tender to the touch; Injection site pain; Injection site redness; Injection site hot to the touch; This is a spontaneous report from a contactable consumer. A 87-year-old non-pregnant female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: ER2613), dose 2 via an un-specified route of administration, administered in Arm Left on 18Mar2021 11:15 as dose 2, single for covid-19 immunisation (at the age of 87-year-old). The patient medical history was not reported. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not received any other medications within 2 weeks of vaccination. The patient previously received first dose of bnt162b2 on an unspecified date for covid-19 immunisation. On 18Mar2021 patient experienced Injection site pain, Injection site redness, Injection site hot to the touch, Thursday 11:15 am shot felt ok through dinner and supper by 8pm feeling sick till Saturday 20Mar then just week , rash and tender to the touch. Friday was extremely rough 15 to 20 on pain scale lost 7 and1/2 pounds. On 20Mar2021 Saturday patient experienced tiredness, Muscle pain, extreme pain in bones every part of her body hurt. Chill, Hot, Cold, joint pain, fever, runny nose, nausea, throwing up, lack of appetite, rash under chin, on arm, weak, weird dreams, when she did sleep and only sleep for short times, glands swollen in neck, sore throat sore mouth, earache, vision poor. Sunday finally ok. Monday (23Mar2021) still week and tired. Tuesday (24Mar2021) Slept late, rashes gone, neck swollen, Rainy day blues. Wednesday (25Mar2021) much back pain during the night took a pain pill (Naproxen) Unger Menthol ointment. Losing voice, feeing weak, need asthma inhaler, pain in check bones, Still feeling weak on the 09Apr2021. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The treatment was not received for adverse event. The patient underwent lab tests and procedures which included pain assessment: 15 to 20 on 19Mar2021, weight decreased: 7 and 1/2 lbs on 19Mar2021. The outcome of the event rash/ rash under chin, on arm was recovered on 24Mar2021. The outcome for other events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth, Visual impairment, Vomiting, Weight decreased
Clinical narrative: back pain; Losing voice; pain in check bones; neck swollen; Rainy day blues; Tiredness; Muscle pain; extreme pain in bones; Chill; Hot; Cold; joint pain; fever; runny nose; nausea; throwing up; lack of appetite; weird dreams; sleep for short times; glands swollen in neck; sore throat; sore mouth; earache; vision poor; extremely rough 15 to 20 on pain scale/ every part of her body hurt; lost 7 and 1/2 pounds; feeling sick; weak; rash/ rash under chin, on arm; tender to the touch; Injection site pain; Injection site redness; Injection site hot to the touch; This is a spontaneous report from a contactable consumer. A 87-year-old non-pregnant female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: ER2613), dose 2 via an un-specified route of administration, administered in Arm Left on 18Mar2021 11:15 as dose 2, single for covid-19 immunisation (at the age of 87-year-old). The patient medical history was not reported. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not received any other medications within 2 weeks of vaccination. The patient previously received first dose of bnt162b2 on an unspecified date for covid-19 immunisation. On 18Mar2021 patient experienced Injection site pain, Injection site redness, Injection site hot to the touch, Thursday 11:15 am shot felt ok through dinner and supper by 8pm feeling sick till Saturday 20Mar then just week , rash and tender to the touch. Friday was extremely rough 15 to 20 on pain scale lost 7 and1/2 pounds. On 20Mar2021 Saturday patient experienced tiredness, Muscle pain, extreme pain in bones every part of her body hurt. Chill, Hot, Cold, joint pain, fever, runny nose, nausea, throwing up, lack of appetite, rash under chin, on arm, weak, weird dreams, when she did sleep and only sleep for short times, glands swollen in neck, sore throat sore mouth, earache, vision poor. Sunday finally ok. Monday (23Mar2021) still week and tired. Tuesday (24Mar2021) Slept late, rashes gone, neck swollen, Rainy day blues. Wednesday (25Mar2021) much back pain during the night took a pain pill (Naproxen) Unger Menthol ointment. Losing voice, feeing weak, need asthma inhaler, pain in check bones, Still feeling weak on the 09Apr2021. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The treatment was not received for adverse event. The patient underwent lab tests and procedures which included pain assessment: 15 to 20 on 19Mar2021, weight decreased: 7 and 1/2 lbs on 19Mar2021. The outcome of the event rash/ rash under chin, on arm was recovered on 24Mar2021. The outcome for other events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Musculoskeletal stiffness, Pain
Clinical narrative: Mild soreness on second day after first dose of vaccination.  The soreness was similar to a mild bruise or a stiff muscle.; Mild soreness on second day after first dose of vaccination.  The soreness was similar to a mild bruise or a stiff muscle.; Mild soreness on second day after first dose of vaccination.  The soreness was similar to a mild bruise or a stiff muscle.; This is a spontaneous report from a non-contactable consumer, the patient.   A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: ER8737 and expiry date was not reported) via an unspecified route of administration, in left arm on 03Apr2021 at 15:15 (at the age of 33-year-old) as dose 1, single for COVID-19 immunisation. The patient medical history was not reported. The patient previously received SCOPOLAMINE PATCHES on an unknown date and experienced skin rash. The patient reported that it was unclear that whether she was allergic to medication or the adhesive (not allergic to any other adhesive). Concomitant medications included levonorgestrel (MIRENA IUD) and sodium fluoride (PREVIDENT TOOTHPASTE) all from unknown dates and for unknown indications. Patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 second day after first dose of vaccination, the patient experienced mild soreness. The soreness was similar to a mild bruise or a stiff muscle. The patient did not receive any treatment for the reported event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event mild soreness similar to a mild bruise or a stiff muscle were recovered on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Blood glucose abnormal, Blood glucose increased, Parosmia
Clinical narrative: Elevated her blood sugar; Enhanced her sensitivity to her allergies; Asthma attack; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: unknown), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. Medical history included diabetes mellitus from an unknown date and unknown if ongoing, hypersensitivity from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. She reported that vaccine elevated her blood sugars, enhanced her sensitivity to her allergies and she had an asthma attack, on unknown date. She was diabetic when she came home from being administered that first dose, she wanted to know what she was supposed to be eating so she always checks her blood sugar that day her blood sugar was 210 which was raised quite a bit from her normal blood sugar level of 150. The day after she was administered the first dose of vaccine, she also had high blood sugars the whole day. Usually when she got up in the morning, she was on special product that keeps her blood sugar low-special product name, lot, NDC, expiry was not provided. The blood sugar test that she took was 150 and then it was later on it was 181 so she could not get her blood sugars down until later that day and not until she called the doctor's office and they advised her to drink a lot of water, which she did and brought the blood sugars down that way. The patient underwent lab tests and procedures which included blood glucose abnormal: 150 Her normal blood sugar level, blood glucose abnormal: 210 which was raised quite a bit from her normal blood sugar, blood glucose abnormal: 150 Blood sugar test that she took was 150 and then it was later on it was 181, blood glucose abnormal: 181. The outcome of events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Epicondylitis
Clinical narrative: Had an exaggeration of Left lateral epicondylitis that was present at the time; With in 2 days wrist pain became pronounced bilaterally/Pronounced joint pain; This is a spontaneous report from a contactable other healthcare professional (patient). A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9264) via an unspecified route of administration in the left arm on 09Feb2021 at 09:45 (at the age of 56-years-old) as a dose 1, single for COVID-19 immunisation. Medical history included lyme disease, my body that had older injuries (Joint pain has become far worse in areas of my body that had older injuries and were not in pain at the time of the 1st injection). The patient had known allergies to shellfish allergy (allergy to clams). The patient did not receive any concomitant medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 09Feb2021 at 04:00, after first dose of vaccine the patient had an exaggeration of left lateral epicondylitis that was present at the time and within 2 days wrist pain became pronounced bilaterally and on the same day at unspecified time the patient experienced pronounced joint pain. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with voltaren gel for ankle and PT for Knee. The clinical outcome of all the events was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia
Clinical narrative: Very bad muscle soreness day after vaccine; Headache; fever; chills; This is a spontaneous report from a non-contactable consumer (Patient). A 23-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Lot Number: unknown) via an unspecified route of administration in the left arm on 06Apr2021 at 17:00 (at the age of 23-year-old) as dose 2, single for COVID-19 immunization. Medical history included gilbert's syndrome and familial tremor both from an unspecified date an unknown if ongoing. The patient had no allergies to medications, food, or other products. The patient did not receive any concomitant medication within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Historical vaccine included first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Lot number: unknown) via an unspecified route of administration in the left arm on 16Mar2021 at 17:30 (at the age of 22-year-old) as dose 1, single for COVID-19 immunization. On 07Apr2021 at 03:00, the patient experienced very bad muscle soreness day after vaccine, headache, fever, and chills. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Outcome of the events were not recovered.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: COVID vaccine reaction; This is a spontaneous report based on the information received by Pfizer (Reference ID: NUS2021US048356_NS) via a contactable consumer (patient). A 61-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced covid vaccine reaction on an unspecified date. Outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Dyspnoea, Malaise, Panic attack, Vomiting
Clinical narrative: Vomited; Short of breath; does not feel well; he was feeling like he was having a panic attack; feeling extremely anxious; This is a spontaneous report from a contactable consumer or other non-healthcare professional (parent).A 18-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation : solution for injection, Batch/Lot Number: EW0150; Expiration Date: 31Jul2021), via an unspecified route of administration in the left arm 09Apr2021 12:15 (at the age of 18-years old) as DOSE 1, SINGLE for covid-19 immunisation in hospital. Medical history included penicillin allergy, anxiety (He has anxiety issues).The patient previously took Amoxicillin and experienced allergy. There were no concomitant medications. History of all previous immunization with the pfizer vaccine considered as suspect was reported as none. No additional vaccines administered on same date of the pfizer suspect was reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine . On 09Apr2021 13:00, the patient experienced feeling extremely anxious and was feeling like he was having a panic attack. On 09Apr2021 13:45, the patient experienced vomited. On 09Apr2021 13:15, the patient experienced short of breath, does not feel well. The reporter was reporting on his son. They both had their first dose of the Pfizer vaccineon the day of reporting.The reporter appointment was at 12:00 and his son at 12:15.They waited onsite as instructed after the vaccine. They went home and then his son felt anxious. He has anxiety issues and he would get like this before so at first he did not think it was related to the vaccine. He had to lay down. He began feeling this way an hour later and then he puked.The Caller asked could it cause this. He has never had this.His son was anxious and walking around, does not feel well, short of breath.Caller thinks this may have anything to do with the vaccine, but that why he was calling to find out.As report proceeded, caller's son was still anxious, but had not vomited again. Caller added his son was allergic to Amoxicillin and Penicillin and the staff was told this prior to his son receiving his first dose. His son has not been diagnosed with anything like this. Caller was contemplating bringing his son back there. He does not know what to do and how to help his son.No emergency room/physician office visit was reported. The outcome of the event feeling anxious was not recovered .No relevant test was reported. The outcome of the events panic attack, vomiting, shortness of breath, does not feel well was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Inflammation, Oropharyngeal pain, Pharyngeal swelling, Pruritus, Spinal pain
Clinical narrative: Itchiness across body; Itchiness  at injection site; sore swollen throat.; Swollen throat; Spine pain; Back inflammation; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: unknown) via an unspecified route of administration in the arm left on 10Apr2021 at 16:45 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history included seizures (temporal limbic/parietal), tourettism (Tourettes Bipolar), post-traumatic stress disorder (Ptsd Seizures), asperger's disorder, obsessive-compulsive disorder, autism, social anxiety disorder (Social anxiety), panic attacks, claustrophobia (Severe claustrophobia), migraine, psychosis, pre-diabetes (hyperglycemic), prostatitis (Prosttitus), irritable bowel syndrome, neuropathy (Severe neuropathy), syncope vasovagal, fainting, dizzy, fever, lower back extra vertebra fused to L5, issues heart condition, loose joints syndrome (high risk break/sprain disorder i.e. elderly youth syndrome), ulcer (issues with ulcers: spicy, citrus, soda, allergy to garlic flavoured cigs), milk allergy, allergy to plants (citrus, hemp, weed, corn), allergy to nuts (walnuts, almonds, cashews), allergy to meat (beef, pork), allergy to vegetable (onion, garlic, carrots), allergy to animal (elm mold, ragweed dog, cat goose) and allergy to all forms of perfume and cologne most forms of incense vape fluids near-lethal allergy to some forms of flavoured cigarettes (throat seals, blackout, cannot breathe). Concomitant medications included buspirone 5 mg, doxycycline and diclofenac sodium (DYCLO). The patient previously took cyclobenzaprine (seizure hiccups, severe fever), meloxicam (seizures, severe suicidal depression, severe fever), diclofenac (seizures, severe fever), gabapentin /neurontin (seizure spasms and convulsive diarrhea), omeprazole (seizure hiccups, severe constipation, stomach pain) and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 17:15, the patient experienced itchiness across body, itchiness at injection site, sore throat, swollen throat, spine pain and back inflammation. Therapeutic measures were taken as a result of events and included treatment with itch cream, ice packs, pain medication. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events itchiness across body, itchiness at injection site, sore throat, swollen throat, spine pain and back inflammation was not recovered at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.